Mid-Year Update on Follicular Lymphoma Pathways for Clinical and Translational Investigations
We are pleased to announce the publication of our latest update, “Follicular Lymphoma: Mid-year Update on Pathways for Clinical and Translational Investigations.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.
Latest follicular lymphoma research updates from recent scientific conferences
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.
What is the potential for minimal residual disease in follicular lymphoma treatment?
Minimal/measurable residual disease refers to the small number of cancer cells remaining in the body after treatment.
Immunotherapy: Can we make better CAR-Ts and bispecific antibodies?
How do we improve immunotherapy treatments to ensure long-lasting effectiveness, fewer side effects, and ensure they are accessible?
Immunotherapy: A breakthrough in follicular lymphoma treatment
Dr Mitchell Smith, FLF CMO, explains Immunotherapy and what it means for people living with follicular lymphoma in terms of treatment.
Latest breakthroughs & updates on FL, from ASH 2023 Annual Meeting
Dr Mitchell Smith, FLF CMO, reports on the most exciting presentations at ASH 2023 including fundamental scientific discoveries and ongoing clinic trials.
Exciting insights about follicular lymphoma at 17-ICML
This article presents key insights from the conference, shedding light on exciting developments in the field. The knowledge and insights we gained left us inspired and energised.
Highlights from our satellite symposium
At the 17th International Conference on Malignant Lymphoma (17-ICML), the FLF hosted their own symposium: “What Will it Take to Cure FL?”. Read more to find out the key takeaways and highlights from the symposium.
Dr Mitchell Smith on Future Directions in FL
Dr Mitchell Smith on Future Directions in FL Dr Mitchell Smith, CMO at the FLF, shares his insights in what the future holds for follicular lymphoma research. In his article, he outlines the key questions in follicular lymphoma, and lays out which areas of research look to be most promising in leading us to better […]